Julie O'Neill, EVP Global Operations at ALEXION PHARMACEUTICALS INC (ALXN), sold 1,625 shares at $120.72 ($195K) on 2018-02-27, disclosed to the SEC on 2018-03-01.
Seasonal sale ($195k) by EVP Global Operations — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.72 | 939 | $113K | 58.2% |
| 2 | $118.61 | 686 | $81K | 41.8% |
| Total | $119.83 avg | 1,625 | $195K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-07 | $248K | — | Filing → |
| ALXN | SELL | 2017-09-05 | $636K | — | Filing → |
| ALXN | SELL | 2017-08-30 | $1.6M | — | Filing → |